EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Community Pharmacists' Perspectives and Experiences of Deprescribing in Québec, Canada: Findings From a Survey

Alexandre Campeau Calfat iD, Béatrice Martin iD, Caroline Sirois iD

Basic & Clinical Pharmacology & Toxicology · 2026-12 · 139 (6)

DOI: 10.1111/bcpt.70328 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, online erschienen am 31.10.2026. Verfasst von Alexandre Campeau Calfat und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Université Laval, Quebec City, Quebec, Canada. Hauptthemen laut MEDLINE: Pharmacists, Deprescriptions, Community Pharmacy Services, Attitude of Health Personnel. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: VITAM - Centre for Sustainable Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Community pharmacists in Quebec can bill for deprescribing. However, uptake remains low. We aimed to explore how community pharmacists perceive and engage in deprescribing.

Methods

Community pharmacists were invited to complete an online survey through a pharmacists' social media group and a newsletter. Data were analysed using descriptive statistics and univariate chi‐square tests.

Results

Among 366 respondents, most were women ( n = 269; 74%), worked full‐time ( n = 282; 77%), had time for clinical interventions ( n = 223; 61%), while 53% ( n = 193) had fewer than 11 years of experience. Three quarters ( n = 271) reported initiating deprescribing at least monthly. Side effects ( n = 273; 75%) and patients' requests ( n = 220; 60%) were more common reasons for deprescribing. More than 70% ( n = 268) reported that prescribers usually accepted recommendations. Initial and follow‐up consultations were systematically billed by 50% ( n = 183) and 48% ( n = 174) of respondents, respectively. Deprescribing interventions and billing practices were more common among pharmacists with dedicated clinical time and those working full time (all p < 0.01). Main barriers to billing were insufficient training ( n = 217; 59%), uncertainty about reimbursement eligibility ( n = 127; 35%) and lack of time ( n = 112; 31%). Integrated software was the most common facilitator ( n = 246; 67%).

Conclusion

Deprescribing was commonly reported among respondents and was often prompted by clinical concerns and patient requests. Billing uncertainties and time constraints remained important barriers, highlighting opportunities to better support deprescribing in community pharmacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PharmacistsDeprescriptionsCommunity Pharmacy ServicesAttitude of Health PersonnelPractice Patterns, Pharmacists'HumansFemaleQuebecMaleSurveys and QuestionnairesAdultMiddle Aged

Stichwörter der Autor:innen

community pharmacy servicesdeprescribingperspectivespharmacistpharmacy practicesurvey

Autor:innen und Institutionen

  • Faculty of Pharmacy, Université Laval, Quebec City, Quebec, Canada.
  • VITAM - Centre for Sustainable Health Research, Quebec City, Quebec, Canada.
  • Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada.

ORCID-Profile: Alexandre Campeau Calfat, Béatrice Martin, Caroline Sirois

Förderung

  • VITAM - Centre for Sustainable Health Research

Zitieren

APA

Campeau Calfat, A., Martin, B., & Sirois, C. (2026). Community Pharmacists' Perspectives and Experiences of Deprescribing in Québec, Canada: Findings From a Survey. Basic & Clinical Pharmacology & Toxicology, 139(6). https://doi.org/10.1111/bcpt.70328

Vancouver

Campeau Calfat A, Martin B, Sirois C. Community Pharmacists' Perspectives and Experiences of Deprescribing in Québec, Canada: Findings From a Survey. Basic & Clinical Pharmacology & Toxicology. 2026;139(6). doi:10.1111/bcpt.70328

BibTeX
@article{CampeauCalfat2026,
  author = {Campeau Calfat, Alexandre and Martin, Béatrice and Sirois, Caroline},
  title = {Community Pharmacists' Perspectives and Experiences of Deprescribing in Québec, Canada: Findings From a Survey},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2026},
  volume = {139},
  number = {6},
  doi = {10.1111/bcpt.70328}
}
Kostenlos starten →